Quick Ratios
Quarterly Results
Profit & Loss
Balance Sheet
Cash Flow
Ratios
Mkt Cap
Market Capitalization
₹62Cr
Rev Gr TTM
Revenue Growth TTM
-14.68%
Peer Comparison
Compare up to 10 companies side by side across valuation, profitability, and growth.

MYSORPETRO
VS
| Quarter | Mar 2023 | Jun 2023 | Sep 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|
|
Growth YoY Revenue Growth YoY% | 28.7 | -100.0 | -15.0 | 165.6 | 135.0 | | 29.4 | 10.4 | -51.0 | -47.7 | -45.1 | 187.0 |
| 11 | 2 | 8 | 7 | 19 | 18 | 11 | 8 | 8 | 8 | 7 | 21 |
Operating Profit Operating ProfitCr |
| -64.7 | | -9.9 | -15.4 | -24.7 | -32.7 | -16.2 | -18.8 | -8.2 | -9.2 | -31.2 | -15.3 |
Other Income Other IncomeCr | 9 | 9 | 3 | 1 | 4 | 20 | 8 | -7 | 4 | 1 | 1 | 0 |
Interest Expense Interest ExpenseCr | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Depreciation DepreciationCr | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| 5 | 7 | 2 | 0 | 0 | 14 | 6 | -8 | 3 | 0 | 0 | -2 |
| 2 | 2 | 0 | 0 | 1 | 5 | 1 | -3 | 1 | 0 | 0 | -1 |
|
Growth YoY PAT Growth YoY% | -65.0 | -26.1 | -63.6 | -100.8 | -119.9 | 67.3 | -208.2 | -20,600.0 | 437.3 | -104.6 | 104.0 | 69.2 |
| 52.2 | | 32.8 | -0.5 | -4.4 | 63.0 | -27.4 | -97.2 | 30.4 | -5.5 | 2.0 | -10.4 |
| 5.1 | 7.9 | 3.5 | -0.1 | -0.1 | 14.4 | -3.8 | -9.4 | 3.4 | -0.6 | 0.1 | -2.9 |
| Financial Year | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|
|
| | -79.4 | 422.9 | -60.2 | 76.0 | -8.5 | -11.9 | 40.1 | 29.8 | 13.7 |
| 25 | 10 | 36 | 16 | 25 | 24 | 26 | 30 | 39 | 44 |
Operating Profit Operating ProfitCr |
| 18.8 | -57.1 | -10.3 | -19.6 | -9.4 | -13.2 | -38.8 | -17.3 | -16.7 | -14.9 |
Other Income Other IncomeCr | 14 | 93 | 23 | 9 | 27 | 46 | 35 | 17 | 24 | 7 |
Interest Expense Interest ExpenseCr | 1 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 |
Depreciation DepreciationCr | 3 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 |
| 16 | 89 | 19 | 5 | 24 | 43 | 27 | 12 | 18 | 1 |
| 1 | 17 | 1 | 1 | 26 | 10 | 6 | 2 | 4 | 0 |
|
| | 388.0 | -75.2 | -72.7 | -146.2 | 1,557.1 | -36.6 | -52.1 | 42.6 | -99.7 |
| 48.5 | 1,150.0 | 54.5 | 37.4 | -9.8 | 156.4 | 112.5 | 38.4 | 42.3 | 0.1 |
| 23.0 | 37.5 | 27.0 | 7.4 | -3.4 | 49.7 | 31.5 | 11.3 | 4.6 | 0.1 |
| Financial Year | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|
Equity Capital Equity CapitalCr | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 |
| 70 | 141 | 157 | 160 | 157 | 188 | 207 | 214 | 214 | 212 |
Current Liabilities Current LiabilitiesCr | 8 | 4 | 5 | 4 | 4 | 3 | 3 | 21 | 7 | 5 |
Non Current Liabilities Non Current LiabilitiesCr | 8 | 1 | 1 | 2 | 27 | 37 | 42 | 60 | 45 | 44 |
Total Liabilities Total LiabilitiesCr |
Current Assets Current AssetsCr | 5 | 17 | 21 | 21 | 29 | 22 | 38 | 24 | 28 | 30 |
Non Current Assets Non Current AssetsCr | 88 | 135 | 149 | 152 | 165 | 212 | 221 | 280 | 245 | 238 |
Total Assets Total AssetsCr |
| Financial Year | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|
Operating Cash Flow Operating Cash FlowCr | 5 | -25 | -2 | -2 | -5 | -2 | -3 | -17 | -7 |
Investing Cash Flow Investing Cash FlowCr | -3 | 25 | 6 | 2 | 6 | 2 | 12 | 23 | 10 |
Financing Cash Flow Financing Cash FlowCr | -3 | -1 | -2 | -2 | -1 | -1 | -2 | -8 | -2 |
|
Free Cash Flow Free Cash FlowCr | 3 | -25 | 1 | -2 | -5 | -3 | -3 | -4 | -7 |
| 35.8 | -34.2 | -8.8 | -41.6 | 221.6 | -5.1 | -14.2 | -167.2 | -52.1 |
CFO To EBITDA CFO To EBITDA% | 92.0 | 688.1 | 46.4 | 79.2 | 231.2 | 60.8 | 41.1 | 372.3 | 131.9 |
| Financial Year | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|
Valuation Ratios Valuation Ratios |
Market Cap Market CapitalizationCr | 62 | 72 | 48 | 20 | 49 | 68 | 73 | 116 | 82 |
Price To Earnings Price To Earnings | 4.3 | 1.0 | 2.7 | 4.1 | 0.0 | 2.1 | 3.5 | 15.5 | 26.9 |
Price To Sales Price To Sales | 2.1 | 11.5 | 1.5 | 1.6 | 2.2 | 3.3 | 4.0 | 4.5 | 2.4 |
Price To Book Price To Book | 0.8 | 0.5 | 0.3 | 0.1 | 0.3 | 0.3 | 0.3 | 0.5 | 0.4 |
| 11.8 | -19.9 | -13.0 | -7.0 | -22.2 | -24.5 | -9.2 | -29.2 | -13.5 |
Profitability Ratios Profitability Ratios |
| 82.6 | 9.2 | 2.0 | 6.0 | 5.7 | 4.8 | 4.3 | 4.1 | 4.5 |
| 18.8 | -57.1 | -10.3 | -19.6 | -9.4 | -13.2 | -38.8 | -17.3 | -16.7 |
| 48.5 | 1,150.0 | 54.5 | 37.4 | -9.8 | 156.4 | 112.5 | 38.4 | 42.3 |
| 20.4 | 60.2 | 11.3 | 3.3 | 14.9 | 22.0 | 12.9 | 5.2 | 8.4 |
| 19.3 | 48.6 | 10.9 | 2.9 | -1.4 | 16.8 | 9.7 | 4.5 | 6.4 |
| 15.8 | 47.1 | 10.5 | 2.8 | -1.2 | 14.0 | 8.0 | 3.3 | 5.2 |
Operational Ratios Operational Ratios |
Solvency Ratios Solvency Ratios |
Liquidity Ratios Liquidity Ratios |
Mysore Petro Chemicals Limited (**MPCL**) is an Indian listed entity that has undergone a fundamental structural transformation. Historically a manufacturer of industrial chemicals, the company has transitioned into a **pure-play trading entity** while aggressively rationalizing its balance sheet through the monetization of non-core assets and the liquidation of underperforming international ventures.
---
### **Core Business Model: Chemical Trading & Distribution**
MPCL currently operates under a single reportable segment: **Trading**. The company leverages its industry expertise to procure and distribute high-demand organic and inorganic chemicals.
* **Key Product Portfolio:** The trading desk focuses primarily on **Phthalic Anhydride**, **Maleic Anhydride**, **Orthoxylene**, and **Benzoic Acid**.
* **Revenue Concentration:** The business maintains a concentrated customer base. As of **March 31, 2025**, **two customers** accounted for significant contributions of **10% or more** of total revenue, representing a combined **₹19.19 crore**.
* **Strategic Associate Holding:** MPCL holds a strategic **13.23% equity stake** in **I G Petrochemicals Limited**, a major player in the petrochemical space, which provides both industrial synergy and investment value.
---
### **Strategic Pivot: Asset Monetization & Project Rationalization**
The company has systematically exited manufacturing and capital-intensive projects to focus on liquidity and lean operations.
* **Ethanol Project Cancellation:** In **July 2024**, MPCL abandoned plans for a **200 KLPD** grain-based distillery in **Raichur, Karnataka**, citing economic unviability. This resulted in a write-off of **Capital Work in Progress (CWIP)** amounting to approximately **₹2.02 crore**.
* **Real Estate Divestment:** To unlock value from idle assets, the company sold its office units in Nariman Point, Mumbai, to its associate, **I G Petrochemicals Limited**, for **₹14.50 crore**. This transaction generated an exceptional profit of **₹14.04 crore** in **FY25**.
* **Legacy Plant Status:** The company’s **Maleic Anhydride** business was sold in **2017**, and its **Phthalic Anhydride** plant has remained shuttered since **July 2013**.
---
### **International Venture: The Q C Polymer Ltd (UK) Exit**
MPCL recently concluded a short-lived attempt to enter the international **rPET recycling** market through its UK subsidiary, **Q C Polymer Limited**. Following operational challenges, the company moved to exit the venture entirely.
| Phase | Timeline | Action/Impact |
| :--- | :--- | :--- |
| **Acquisition** | **Jan - July 2024** | Rapidly increased stake from **60%** to **85%** via debt infusion and equity purchase. |
| **Loss of Control** | **Oct 28, 2024** | Appointment of an administrator; control ceased. |
| **Liquidation** | **Dec 23, 2024** | Initiation of **voluntary liquidation**. |
| **Financial Hit** | **FY 2024-25** | **₹25.35 crore** impairment (Standalone); **₹11.8 crore** deconsolidation loss (Consolidated). |
*Note: While the subsidiary has filed an insurance claim for **GBP 0.13 crore**, MPCL has adopted a conservative accounting stance, recognizing no potential recovery until cash is realized.*
---
### **Financial Position & Capital Allocation**
MPCL maintains an exceptionally conservative balance sheet, characterized by a **debt-free** status and high liquidity.
**Comparative Capital Structure (₹ in lakhs)**
| Particulars | March 31, 2025 | March 31, 2024 |
| :--- | :---: | :---: |
| **Equity Attributable to Owners** | **22,068.61** | **22,025.16** |
| **Total Debt** | **0.00** | **50.89** |
| **Gearing Ratio** | **0.00%** | **0.23%** |
* **Liquidity Management:** The company has sanctioned working capital limits exceeding **₹5 crore**, which remained **unutilized** throughout the fiscal year.
* **Investment Portfolio:** MPCL manages a diverse portfolio of **Alternative Investment Funds (AIF)**, mutual funds, and fixed deposits. As of **March 31, 2024**, capital commitments to these funds stood at **₹14.38 crore**.
* **Shareholder Returns:** Despite the UK subsidiary write-offs, the board recommended a **20% dividend** (**₹2 per share**) for **FY25**, totaling an outgo of **₹1.32 crore**.
---
### **Risk Profile & Contingent Liabilities**
The company’s primary risks are legal and legacy-related rather than operational.
* **Raichur Labor Litigation:** Following a **March 2024** Industrial Tribunal order, MPCL was directed to pay **₹15.56 crore** in benefits to the workmen's union of the closed Raichur plant. The company has obtained a **stay of execution** from the **High Court of Karnataka** and treats this as a **contingent liability** rather than a provision.
* **Taxation Disputes:** The company reports disputed taxation matters totaling **₹23.98 lakhs**.
* **Risk Mitigation:** Financial risks are managed by a dedicated **Treasury Department**. Credit risk is mitigated through individual risk limits for customers, while market risks are addressed through hedging strategies for foreign currency when applicable.
---
### **Governance & Leadership**
The company is led by experienced promoters with a focus on long-term stability and board independence.
* **Key Executives:**
* **Shri M M Dhanuka:** Re-appointed as **Managing Director** until **August 2027**.
* **Shri Satyanarayan Bankatlal Maheshwari:** Appointed as **Executive Director** (Whole-Time Director) through **September 2027**.
* **Shri Mayank Dhanuka:** Appointed as **Non-Executive Director** in **March 2025**.
* **Board Oversight:** The board includes independent directors **Dr. Vaijayanti Pandit**, **Shri Rajesh R Muni**, and **Shri Shanti Kumar Loonker**, ensuring robust corporate governance and audit committee oversight.